Mode
Text Size
Log in / Sign up
N/A Completed N=250 Randomized Single-blind Treatment

1/2 A Multi-site Systems Intervention for Unemployed Persons With Social Anxiety

Source: ClinicalTrials.gov NCT02633267 ↗
Enrolled (actual)
250
Serious AEs
0.0%
Results posted
Jun 2022
Primary outcomePrimary: Liebowitz Social Anxiety Scale — 81.05; 82.74; 64.11; 73.05 score on a scale

Summary

Social anxiety disorder is a highly prevalent condition that interferes with employment. Prior research indicates that social anxiety disorder interferes with work attainment. This project involves a two-site randomized trial of a community-based cognitive-behavioral intervention to reduce social anxiety and improve employment outcomes among unemployed persons with social anxiety disorder.

Outcome Measures

OutcomeResultp-value
PRIMARY
Liebowitz Social Anxiety Scale
81.05; 82.74; 64.11; 73.05; 57.78; 65.82
SECONDARY
Patient Health Questionnaire
10.99; 11.52; 7.79; 9.26; 7.70; 8.17
SECONDARY
Hours Worked Per Week
14.2; 15.39; 16.57; 17.94; 18.92; 20.44

Eligibility Criteria

Inclusion Criteria

  • Participants will be:
  • JVS service-seeking adults who are unemployed
  • Screen positive for social anxiety, and
  • Meet diagnostic criteria for social anxiety.
  • Potential Participant taking psychotropic medications will be offered participation without restriction.

Exclusion Criteria

  • Presence of any of the following:
  • Substance dependence; current opiates or freebase cocaine; schizophrenia, other psychotic symptoms and/or manic symptoms that would interfere with study participation
  • Current anorexia nervosa
  • Prior course of cognitive behavioral therapy for social anxiety (at least 8 sessions)
  • Prominent suicidal/homicidal ideation with imminent risk
  • Persons meeting diagnostic criteria for substance abuse if they are unable to attend sessions while not under the influence, except for those abusing opiates or freebase cocaine who will be excluded
  • Persons who score below 6th grade reading level
  • Non-English speaking participants
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02633267). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search